EP4454638A4 - Zusammensetzung mit efinaconazol zur behandlung von onychomykose - Google Patents

Zusammensetzung mit efinaconazol zur behandlung von onychomykose

Info

Publication number
EP4454638A4
EP4454638A4 EP22912054.8A EP22912054A EP4454638A4 EP 4454638 A4 EP4454638 A4 EP 4454638A4 EP 22912054 A EP22912054 A EP 22912054A EP 4454638 A4 EP4454638 A4 EP 4454638A4
Authority
EP
European Patent Office
Prior art keywords
onychomycose
efinaconazole
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22912054.8A
Other languages
English (en)
French (fr)
Other versions
EP4454638A1 (de
Inventor
Joo-Hyung Kim
Moon-Seok Han
Woo-Young Lee
Sang-Lin Kim
Byoung-Ki Lee
Han-Ki Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SINSIN PHARM CO Ltd
Original Assignee
SINSIN PHARM CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SINSIN PHARM CO Ltd filed Critical SINSIN PHARM CO Ltd
Publication of EP4454638A1 publication Critical patent/EP4454638A1/de
Publication of EP4454638A4 publication Critical patent/EP4454638A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
EP22912054.8A 2021-12-23 2022-12-23 Zusammensetzung mit efinaconazol zur behandlung von onychomykose Pending EP4454638A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020210186651A KR20230096779A (ko) 2021-12-23 2021-12-23 에피코나졸을 함유하는 조갑 진균증 치료용 조성물
PCT/KR2022/021257 WO2023121421A1 (ko) 2021-12-23 2022-12-23 에피나코나졸을 함유하는 조갑 진균증 치료용 조성물

Publications (2)

Publication Number Publication Date
EP4454638A1 EP4454638A1 (de) 2024-10-30
EP4454638A4 true EP4454638A4 (de) 2025-12-10

Family

ID=86903225

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22912054.8A Pending EP4454638A4 (de) 2021-12-23 2022-12-23 Zusammensetzung mit efinaconazol zur behandlung von onychomykose

Country Status (3)

Country Link
EP (1) EP4454638A4 (de)
KR (1) KR20230096779A (de)
WO (1) WO2023121421A1 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019234546A1 (en) * 2018-06-04 2019-12-12 Zenvision Pharma Llp Antifungal cuticle oil composition
WO2020231800A1 (en) * 2019-05-10 2020-11-19 Encube Ethicals Private Limited Topical antifungal formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160087898A (ko) * 2013-11-22 2016-07-22 다우 파마슈티컬 사이언시즈, 인코포레이티드 항­감염 방법，조성물，및 장치
US20190142800A1 (en) * 2016-06-13 2019-05-16 Vyome Therapeutics Limited Synergistic antifungal compositions and methods thereof
WO2019135123A1 (en) * 2018-01-02 2019-07-11 Nal Pharmaceutical Group Limited Liquid dosage form for topical application
KR102060546B1 (ko) 2019-06-07 2019-12-30 주식회사 바이오빌리프 에피나코나졸을 함유하는 용액 형태의 국소 투여용 약학 조성물
KR102394599B1 (ko) * 2020-03-19 2022-05-06 동아에스티 주식회사 에피나코나졸을 함유하는 국소 투여용 약학 조성물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019234546A1 (en) * 2018-06-04 2019-12-12 Zenvision Pharma Llp Antifungal cuticle oil composition
WO2020231800A1 (en) * 2019-05-10 2020-11-19 Encube Ethicals Private Limited Topical antifungal formulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2023121421A1 *

Also Published As

Publication number Publication date
EP4454638A1 (de) 2024-10-30
WO2023121421A1 (ko) 2023-06-29
KR20230096779A (ko) 2023-06-30

Similar Documents

Publication Publication Date Title
EP3784260A4 (de) Zusammensetzung zur behandlung von hautleiden
EP4017489C0 (de) Dgd1202 zur behandlung von kras-mutierten krebsen
EP3790563A4 (de) Zusammensetzung zur behandlung von hautleiden
EP3768240A4 (de) Ionische flüssige zusammensetzungen zur behandlung von rosacea
EP3603636A4 (de) Gegen s1pr4 gerichtete zusammensetzung zur prävention oder behandlung von nichtalkoholischer steatohepatitis
EP4085144A4 (de) Zusammensetzungen zur behandlung von friedreich-ataxie
EP3897626C0 (de) Tinostamustin zur behandlung von multiplem myelom
EP4096675C0 (de) Zusammensetzungen zur behandlung von long covid
EP3813793A4 (de) Zusammensetzung zur behandlung von augenhyperämie und verfahren zur behandlung von augenhyperämie damit
EP3689875A4 (de) Verwendung von triazolopyrimidin-, triazolopyridinverbindungen und zusammensetzung davon zur behandlung von prc2-vermittelten erkrankungen
EP3737370A4 (de) Zusammensetzungen und verfahren zur behandlung von schmerzen mit wogonin
EP3719032A4 (de) Zusammensetzung zur vorbeugung oder behandlung von haarausfall
EP3902976A4 (de) Verfahren und zusammensetzungen zur behandlung von kalk
EP3795175A4 (de) Verwendung zur vorbeugung und behandlung von mit myeloischen suppressorzellen verwandten krankheiten
EP4058041C0 (de) Zusammensetzung zur behandlung von epithelialen läsionen
EP4034108A4 (de) Azaindolcarboxamidverbindungen zur behandlung von mykobakteriellen infektionen
EP4440574A4 (de) Verwendung von pipendoxifen zur behandlung von sars-cov-2-infektionen
EP4027984A4 (de) Kombinationstherapie zur behandlung von migräne
EP3848029A4 (de) Medizinische zusammensetzung zur behandlung von hirninfarkten
EP3777848C0 (de) Zusammensetzung zur prävention oder behandlung von schlaganfall
EP4210720C0 (de) Probiotische zusammensetzungen zur behandlung von akne
EP4149451A4 (de) Cysteamin zur behandlung von sars-cov-2-infektion
EP4096783A4 (de) Zusammensetzungen zur behandlung von hämorrhoiden
EP3761990C0 (de) Zusammensetzungen zur behandlung von infektionen in füssen
EP4454638A4 (de) Zusammensetzung mit efinaconazol zur behandlung von onychomykose

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240723

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20251111

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/08 20060101AFI20251105BHEP

Ipc: A61K 47/14 20170101ALI20251105BHEP

Ipc: A61K 47/10 20170101ALI20251105BHEP

Ipc: A61K 31/454 20060101ALI20251105BHEP

Ipc: A61P 31/10 20060101ALI20251105BHEP